NIH-funded research NIH-funded research

Finding new biomarkers for portopulmonary hypertension

Official title: Biomarker Discovery in Portopulmonary Hypertension

Funded at University of Cincinnati · NIH-11071981 · Data updated 2026-11-12

This study is looking for new ways to diagnose and understand portopulmonary hypertension in people with liver disease, so we can better predict how serious the condition is and help improve treatment for patients.

More Hypertension research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startApril 21, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$204,228
NIH project number5K23HL164971-03
Project IDNIH-11071981 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with portopulmonary hypertension who also have underlying liver disease.

Less likely to help

Patients without liver disease or those not diagnosed with portopulmonary hypertension may not benefit from this research.

What this research studies

This research focuses on portopulmonary hypertension (PoPH), a severe condition affecting patients with liver disease. It aims to identify new biomarkers that can accurately diagnose and predict the severity of PoPH, which is currently challenging due to the limitations of existing markers. By using advanced techniques like next-generation sequencing, the study will analyze liver tissue and validate findings through a biorepository. This approach seeks to enhance our understanding of the disease mechanisms and improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnoses and better treatment strategies for patients with portopulmonary hypertension.

How similar studies have gone: Previous research has shown promise in biomarker discovery for other forms of pulmonary hypertension, suggesting potential for success in this novel approach.

Where this research is happening

  • University of Cincinnati
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Jose, Arun — University of Cincinnati
  • Study coordinator: Jose, Arun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.